CTSH

Cognizant Technology Solutions

$61.87

+1.56%
Aug 21, 2026
Bobby Quantitative Model
Cognizant Technology Solutions is a multinational IT services provider offering consulting, technology, and business process outsourcing services, primarily serving enterprise clients in financial services, healthcare, and resources industries. As a major player in the global IT services market, Cognizant leverages a global delivery model with a large offshore workforce in India to offer cost-effective solutions. The current investor narrative centers on the company's turnaround efforts amid a challenging demand environment, with recent stock volatility reflecting concerns about growth deceleration and the impact of AI on traditional IT services, while management focuses on margin improvement and strategic investments in digital capabilities.

People also watch

IBM

IBM

IBM

Analysis
Accenture

Accenture

ACN

Analysis
Fiserv

Fiserv

FISV

Analysis
Fidelity National Information Services

Fidelity National Information Services

FIS

Analysis
CDW

CDW

CDW

Analysis

BobbyInvestment Opinion: Should I buy CTSH Today?

Based on the analysis, I rate CTSH a 'Hold' with a cautious tilt towards 'Buy' on dips. The analyst consensus is 'buy' with an average target of $63.94, implying 8.8% upside, but the wide target range ($42-$84) reflects high uncertainty. The thesis is that the stock is undervalued on forward earnings, but the lack of growth catalysts limits near-term upside.

Sign up to view all

CTSH 12-Month Price Forecast

The AI assessment is neutral with medium confidence. The stock is undervalued on forward earnings, but the growth trajectory is weak, and the market is pricing in a turnaround that has yet to materialize. The recent rebound is encouraging, but it is not yet supported by fundamental improvements. I would upgrade to bullish if revenue growth accelerates above 8% and the company demonstrates AI-driven wins, and downgrade to bearish if growth falls below 3% or the stock breaks below $50.

Historical Price
Current Price $61.87
Average Target $64.00
High Target $84.00
Low Target $42.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Cognizant Technology Solutions's 12-month outlook, with a consensus price target around $63.94 and implied upside of +3.4% versus the current price.

Average Target

$63.94

0 analysts

Implied Upside

+3.4%

vs. current price

Analyst Count

covering this stock

Price Range

$42 - $84

Analyst target range

Cognizant is covered by 25 analysts, with a consensus recommendation of 'buy' and a mean rating of 2.17 (where 1 is strong buy and 5 is sell). The average target price is $63.94, implying an upside of 8.8% from the current price of $58.79. The distribution of ratings is not provided, but the 'buy' consensus suggests a generally bullish stance. The target range spans from a low of $42.00 to a high of $84.00, with the high target implying a 42.9% upside, while the low target suggests a 28.6% downside. The wide spread of $42 indicates significant uncertainty about the company's future performance, reflecting divergent views on the impact of AI and demand recovery. Recent ratings actions have been mostly neutral, with no major upgrades or downgrades, indicating a wait-and-see approach among analysts.

Drowning in data?

Find the real signal!

Bulls vs Bears: CTSH Investment Factors

Cognizant presents a mixed picture: it is fundamentally profitable with a strong balance sheet and trades at a deep discount to peers on forward earnings, but its growth has decelerated and the stock has underperformed significantly. The bull case rests on the potential for margin expansion and a re-rating, while the bear case centers on demand weakness and AI disruption. Currently, the bearish evidence is slightly stronger given the revenue plateau and negative relative strength, but the recent 36% rebound and analyst optimism suggest a turning point may be near. The key tension is whether the company can reignite growth through AI and digital services, which would justify the low forward PE and drive the stock toward the average target.

Bullish

  • Forward PE at 58% discount to peers: CTSH trades at a forward PE of 9.31x versus the industry average of 22x, a 58% discount. This implies the market is pricing in significant earnings growth or a re-rating, offering substantial upside if the company delivers on margin expansion.
  • Strong balance sheet with low debt: Debt-to-equity is only 0.10x and current ratio is 2.34x, indicating a solid liquidity position. This financial flexibility supports continued buybacks and dividends, with a payout ratio of 27.4% and a dividend yield of 1.53%.
  • Analyst consensus is Buy with 8.8% upside: 25 analysts rate CTSH a 'buy' with a mean rating of 2.17 and an average target price of $63.94, implying 8.8% upside from the current $58.79. The high target of $84 suggests 42.9% potential if the turnaround succeeds.
  • Recent momentum with 36% 1-month gain: The stock has surged 36.15% in the past month, recovering from the June low of $38.73 to $58.79. This rebound, coupled with a 24.7% 3-month gain, signals improving investor sentiment and a potential bottoming process.

Bearish

  • Revenue growth decelerating to 5.8%: Q1 2026 revenue grew only 5.83% YoY, down from earlier quarters, and Q2 2025 revenue was $5.245 billion, showing a plateau. This deceleration suggests the demand environment remains weak, with no clear growth driver emerging.
  • Stock down 15.3% over 1 year: CTSH has underperformed the S&P 500 by 35.6 percentage points over the past year, with a 1-year price change of -15.25% versus the index's +20.37%. This persistent underperformance reflects ongoing concerns about growth and AI disruption.
  • High PEG ratio of 20.6 signals overvaluation: The PEG ratio of 20.57 is extremely high, indicating that the stock is expensive relative to its growth rate. This suggests that the market is paying a premium for earnings that are not growing fast enough to justify the valuation.
  • Max drawdown of -55.3% highlights volatility: The stock has experienced a maximum drawdown of -55.33%, and the 52-week range is wide ($37.08 to $87.03). This volatility indicates high risk, with the stock currently at 67.6% of its range, closer to the lows.

CTSH Technical Analysis

Cognizant's stock has been in a pronounced downtrend over the past year, with a 1-year price change of -15.25%, significantly underperforming the S&P 500's +20.37% gain. The current price of $58.79 sits at approximately 67.6% of its 52-week range (low $37.08, high $87.03), indicating the stock is closer to its lows than highs, reflecting persistent selling pressure. This positioning suggests a bearish sentiment, though the recent recovery from the June lows hints at a potential bottoming process.

Beta

0.81

0.81x market volatility

Max Drawdown

-55.3%

Largest decline past year

52-Week Range

$37-$87

Price range past year

Annual Return

-13.0%

Cumulative gain past year

PeriodCTSH ReturnS&P 500
1m+43.3%+2.5%
3m+17.3%+2.7%
6m-4.9%+11.1%
1y-13.0%+20.5%
ytd-23.9%+12.3%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

CTSH Fundamental Analysis

Cognizant's revenue has shown modest growth, with Q1 2026 revenue of $5.413 billion, up 5.83% year-over-year, and sequential growth from $5.333 billion in Q4 2025. However, the growth rate is decelerating compared to earlier quarters, with Q2 2025 revenue of $5.245 billion and Q3 2025 at $5.415 billion, indicating a plateau. The company's revenue segments show Financial Services as the largest at $1.644 billion, followed by Healthcare at $1.579 billion, Products and Resources at $1.321 billion, and Communication, Media and Technology at $869 million, with no clear growth driver emerging.

Quarterly Revenue

$5.4B

2026-03

Revenue YoY Growth

+5.8%

YoY Comparison

Gross Margin

29.6%

Latest Quarter

Free Cash Flow

$2.5B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Communication, Media and Technology
Financial Services
Healthcare Segment
Products and Resources

Open an Account, get $2 TSLA now!

Valuation Analysis: Is CTSH Overvalued?

Given Cognizant's positive net income, the PE ratio is the primary valuation metric. The trailing PE is 18.20x, while the forward PE is 9.31x, a significant discount that implies the market expects earnings growth or a re-rating. The gap between trailing and forward PE suggests analysts anticipate a substantial increase in earnings, likely due to margin expansion or cost cuts. Compared to the industry average PE of 22x (based on available data), Cognizant's trailing PE of 18.20x is at a 17% discount, while its forward PE of 9.31x is at a 58% discount, indicating the stock is undervalued relative to peers on a forward basis.

PE

18.2x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 11x~21x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

9.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial risks include a decelerating revenue growth rate of 5.8% YoY, which could pressure margins if fixed costs remain. The company's net margin of 10.6% and operating margin of 16.7% are respectable, but any further slowdown could compress them. Debt levels are low (D/E 0.10x), but the high PEG ratio of 20.6 suggests the market expects significant growth that may not materialize, leading to potential de-rating. Cash flow is positive at $2.47B TTM, but if growth stalls, the stock could lose its valuation support.